The global Interventional Cardiology & Peripheral Vascular Devices Market was valued at USD 21.21 billion in 2016 and is projected to reach USD 38.28 billion by 2025, growing at a CAGR of 6.78% from 2017 to 2025.
The increase in geriatric population and Heart related health issues in the middle age group population is enforcing the use and R&D in treatment of cardiovascular disorders. The market is therefore growing and is expected to grow at a steady rate till 2025 courtesy major investments in the market.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing Geriatric population
1.2 Growing demand of minimally invasive devices and surgical procedures
1.3 Growing Technical assistance and advancements in cardiovascular and peripheral vascular techniques
2. Market Restraints
2.1 Availability of alternate effective treatments
2.2 Product failure
Market Segmentation:
The global Interventional Cardiology & Peripheral Vascular Devices Market is segmented on the basis of the product and technique market involved:
1. Angioplasty Market, by Type:
1.1 Old/Normal Balloons
1.2 Cutting and Scoring Balloons
1.3 Drug-Eluting Balloons
1.4 Angioplasty Balloon Material
1.4.1 Non-Compliant Balloons
1.4.2 Semi-Compliant Balloons
1.4.3 Low-Compliant Balloons
1.5 Angioplasty Balloon Platforms
1.5.1 Over-The-Wire Balloon Catheters
1.5.2 Rapid Exchange (RX) Balloon Catheters
1.5.3 Fixed-Wire Balloon Catheters
2. Angioplasty Stent Market, by Type:
2.1 Angioplasty Stents, By Type
2.1.1 Bare-Metal Stents
2.1.2 Drug-Eluting Stents
2.1.3 Bioabsorbable Stents
2.2 Angioplasty Stents, By Delivery Platform
2.2.1 Self-Expanding Stent
2.2.2 Balloon-Expandable Stent
3. Angioplasty Market, by Procedure:
3.1 Plain Old Balloon Angioplasty (Poba)
3.2 Percutaneous Transluminal Coronary Angioplasty (PTCA)
3.3 Percutaneous Transluminal Angioplasty (PTA)
4. Catheters Market, by Type:
4.1 Angiography Catheters
4.2 IVUS/OCT Catheters
4.3 Guiding Catheters
5. Inferior Vena Cava (IVC) Filters Market, By Type:
5.1 Retrievable Filters
5.2 Permanent Filters
6. Interventional Cardiology and Peripheral Vascular Device Accessories Market, By Type:
6.1 Guidewires
6.2 Vascular Closure Devices
6.3 Introducer Sheaths
6.4 Balloon Inflation Devices
7. Endovascular Aneurysm Repair (EVAR) Stent Grafts Market, By Type:
7.1 Abdominal Aortic Aneurysms
7.2 Thoracic Aortic Aneurysms
8. Hemodynamic Flow Alteration Devices Market, By Type:
8.1 Embolic Protection Devices
8.2 Chronic Total Occlusion Devices
9. Plaque Modification Devices Market, By Type:
9.1 Atherectomy Devices
9.2 Thrombectomy Devices
10. Global Interventional Cardiology & Peripheral Vascular Devices Market, by Region:
10.1 North America (U.S., Canada, Mexico)
10.2 Europe (Germany, UK, France, Rest of Europe)
10.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
10.4 Latin America (Brazil, Argentina, Rest of Latin America)
10.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Medtronic PLC
2. Boston Scientific Corporation
3. Abbott Laboratories
4. Cordis Corporation (A Subsidiary of Johnson & Johnson Services, Inc.)
5. Accessclosure, Inc. (A Subsidiary of Cardinal Health, Inc.)
6. B. Braun Melsungen AG
7. Biosensors International Group Ltd.
8. C.R. Bard, Inc.
9. St. Jude Medical, Inc.
10. Terumo Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Interventional Cardiology & Peripheral Vascular Devices Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 ANGIOPLASTY MARKET, BY TYPE
5.1 Overview
5.1.1 Old/Normal Balloons
5.1.2 Cutting and Scoring Balloons
5.1.3 Drug-Eluting Balloons
5.2 Angioplasty Balloon Material
5.2.1 Non-Compliant Balloons
5.2.2 Semi-Compliant Balloons
5.2.3 Low-Compliant Balloons
5.3 Angioplasty Balloon Platforms
5.3.1 Over-The-Wire Balloon Catheters
5.3.2 Rapid Exchange (RX) Balloon Catheters
5.3.3 Fixed-Wire Balloon Catheters
6 ANGIOPLASTY STENT MARKET, BY TYPE
6.1 Angioplasty Stents, By Type
6.1.1 Bare-Metal Stents
6.1.2 Drug-Eluting Stents
6.1.3 Bioabsorbable Stents
6.2 Angioplasty Stents, By Delivery Platform
6.2.1 Self-Expanding Stent
6.2.2 Balloon-Expandable Stent
7 ANGIOPLASTY MARKET, BY PROCEDURE
7.1 Plain Old Balloon Angioplasty (Poba)
7.2 Percutaneous Transluminal Coronary Angioplasty (PTCA)
7.3 Percutaneous Transluminal Angioplasty (PTA)
8 CATHETERS MARKET, BY TYPE
8.1 Angiography Catheters
8.2 IVUS/OCT Catheters
8.3 Guiding Catheters
9 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE
9.1 Retrievable Filters
9.2 Permanent Filters
10 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICE ACCESSORIES MARKET, BY TYPE
10.1 Guidewires
10.2 Vascular Closure Devices
10.3 Introducer Sheaths
10.4 Balloon Inflation Devices
11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET, BY TYPE
11.1 Abdominal Aortic Aneurysms
11.2 Thoracic Aortic Aneurysms
12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE
12.1 Embolic Protection Devices
12.2 Chronic Total Occlusion Devices
13 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE
13.1 Atherectomy Devices
13.2 Thrombectomy Devices
14 GLOBAL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY
14.1 Overview
14.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
14.2.1 U.S.
14.2.2 Canada
14.2.3 Mexico
14.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
14.3.1 Germany
14.3.2 U.K.
14.3.3 France
14.3.4 Rest of Europe
14.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
14.4.1 China
14.4.2 Japan
14.4.3 India
14.4.4 Rest of Asia Pacific
14.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
14.5.1 Brazil
14.5.2 Argentina
14.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
15 GLOBAL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Company Market Share
15.3 Vendor Landscape
15.4 Key Development Strategies
16 COMPANY PROFILES
16.1 Medtronic PLC
16.1.1 Overview
16.1.2 Financial Performance
16.1.3 Product Outlook
16.1.4 Key Developments
16.2 Boston Scientific Corporation
16.2.1 Overview
16.2.2 Financial Performance
16.2.3 Product Outlook
16.2.4 Key Developments
16.3 Abbott Laboratories
16.3.1 Overview
16.3.2 Financial Performance
16.3.3 Product Outlook
16.3.4 Key Developments
16.4 Cordis Corporation
16.4.1 Overview
16.4.2 Financial Performance
16.4.3 Product Outlook
16.4.4 Key Developments
16.5 Accessclosure, Inc.
16.5.1 Overview
16.5.2 Financial Performance
16.5.3 Product Outlook
16.5.4 Key Developments
16.6 B. Braun Melsungen AG
16.6.1 Overview
16.6.2 Financial Performance
16.6.3 Product Outlook
16.6.4 Key Developments
16.7 Biosensors International Group Ltd.
16.7.1 Overview
16.7.2 Financial Performance
16.7.3 Product Outlook
16.7.4 Key Developments
16.8 C.R. Bard, Inc.
16.8.1 Overview
16.8.2 Financial Performance
16.8.3 Product Outlook
16.8.4 Key Developments
16.9 St. Jude Medical, Inc.
16.9.1 Overview
16.9.2 Financial Performance
16.9.3 Product Outlook
16.9.4 Key Developments
16.10 Terumo Corporation
16.10.1 Overview
16.10.2 Financial Performance
16.10.3 Product Outlook
16.10.4 Key Developments
17 Appendix
17.1 Related Reports